Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q80045743)
Watch
English
Treatment of chronic hepatitis B
scientific article published on 01 August 2006
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16883349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16883349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Treatment of chronic hepatitis B
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16883349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16883349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 December 2019
main subject
chronic hepatitis B
1 reference
based on heuristic
inferred from title
chronic hepatitis
1 reference
based on heuristic
inferred from title
author name string
Smruti R Mohanty
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16883349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16883349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 December 2019
Sonia S Kupfer
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16883349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16883349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 December 2019
Vijay Khiani
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16883349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16883349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 December 2019
publication date
1 August 2006
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16883349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16883349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 December 2019
published in
Nature Reviews Gastroenterology & Hepatology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16883349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16883349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 December 2019
volume
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16883349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16883349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 December 2019
issue
8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16883349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16883349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 December 2019
page(s)
446-458
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16883349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16883349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 December 2019
exact match
https://scigraph.springernature.com/pub.10.1038/ncpgasthep0550
0 references
cites work
The discovery of the hepatitis viruses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Estimating the world cancer burden: Globocan 2000.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus: significance of genotypes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon-alpha for HBeAg-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment with interferons (including pegylated interferons) in patients with hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Development of pegylated interferons for the treatment of chronic hepatitis C.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification of the major positional isomer of pegylated interferon alpha-2b
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of lamivudine on replication of hepatitis B virus in HIV-infected men.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine for patients with chronic hepatitis B and advanced liver disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The hepatitis B virus and common mutants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term safety of lamivudine treatment in patients with chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Histological outcome during long-term lamivudine therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Virologic response and resistance to adefovir in patients with chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus genotypes in the United States: results of a nationwide study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B genotypes and the response to interferon therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPGASTHEP0550
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1038/NCPGASTHEP0550
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16883349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16883349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 December 2019
PubMed publication ID
16883349
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16883349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16883349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
